Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry.

Authors :: Aubert H
Arlegui H
De Rycke Y
Bachelez H
Beylot-Barry M
Dupuy A
Joly P
Jullien D
Mahé E
Paul C
Richard MA
Sbidian E
Viguier M
Chosidow O
Tubach F
Bénéton N
Source :: The British journal of dermatology [Br J Dermatol] 2023 Jan 23; Vol. 188 (1), pp. 150-152.
Publication Year :: 2023
Abstract: Competing Interests: Conflicts of interest: M.B.-B. is a consultant for AbbVie, Celgene, Janssen-Cilag, Lilly, Novartis, Medac and UCB. N.B. is a consultant for Novartis, Celgene, MSD, Janssen, Lilly, Pfizer and AbbVie. P.J. is a consultant for AbbVie, Celgene, Janssen-Cilag, Lilly and Novartis. D.J. is a consultant for AbbVie, Amgen, Celgene, Fresenius-Kabi, Janssen-Cilag, LEO, Lilly, Pfizer, MEDAC, Novartis and UCB. E.M. is a consultant for AbbVie, LEO Pharma, Celgene, Pfizer, Janssen-Cilag and Novartis. C.P. is a consultant for AbbVie, Almirall, Amgen, Boerhinger, Celgene, Janssen-Cilag, LEO Pharma, Lilly, Pfizer, Novartis, Pierre Fabre, Sanofi and UCB. M.-A.R. is a consultant for AbbVie, Amgen, Boehringer, Celgene, Janssen-Cilag, LEO Pharma, Lilly, Nordic, Novartis, Pfizer and Medac. H.B. is a consultant for AbbVie, Almirall, Amgen, Biocad, Boerhinger, Celgene, Dermavant, Janssen, LEO Pharma, Eli Lilly, Mylan, Novartis, Pfizer, Pierre Fabre, Sun Pharmaceuticals and UCB. H.A. is a consultant for AbbVie, Novartis, Janssen-Cilag, Almirall, Leo and Lilly.

Full Text Access

Tools